Evidence map›Paper›PMID 31772175›Full record

ArticleNature communications2019

Author Correction: NFAT primes the human RORC locus for RORγt expression in CD4+T cells.

Hanane Yahia-Cherbal, Magda Rybczynska, Domenica Lovecchio, Tharshana Stephen, Chloé Lescale, Katarzyna Placek, Jérome Larghero, Lars Rogge, Elisabetta Bianchi

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Hanane Yahia-CherbalInstitut Pasteur, Immunoregulation Unit, Department of Immunology, Paris, France.
Magda RybczynskaInstitut Pasteur, Immunoregulation Unit, Department of Immunology, Paris, France.
Domenica LovecchioInstitut Pasteur, Immunoregulation Unit, Department of Immunology, Paris, France.ORCID http://orcid.org/0000-0002-6297-8384
Tharshana StephenInstitut Pasteur, Unité de Technologie et Service Cytométrie et Biomarqueurs (UTechS CB), Centre de recherche translationnelle (CRT), Paris, France.
Chloé LescaleInstitut Pasteur, Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre le Cancer, Department of Immunology, Department of Genomes and Genetics, Paris, France.
Katarzyna PlacekInstitut Pasteur, Immunoregulation Unit, Department of Immunology, Paris, France.
Jérome LargheroAssistance Publique-Hopitaux de Paris, Hôpital Saint-Louis, Cell Therapy Unit and Cord Blood Bank; CIC de Biothérapies, CBT501, Paris, France.
Lars RoggeInstitut Pasteur, Immunoregulation Unit, Department of Immunology, Paris, France.ORCID http://orcid.org/0000-0003-1262-9204
Elisabetta BianchiInstitut Pasteur, Immunoregulation Unit, Department of Immunology, Paris, France. elisabetta.bianchi@pasteur.fr.ORCID http://orcid.org/0000-0001-6612-8881
Institut Pasteur · FRAssistance Publique – Hôpitaux de Paris · FRUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31772175
PMCPMC6879466
OpenAlexW2990896365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.